Intensive Lipitor therapy significantly reduced hsCRP levels further than low-dose LipitorMagna Carta 8 Feb 2009
Lipitor appears to reduce risk of cardiovascular events compared with simvastatinmagna Carta 11 Dec 2008
Intensive Lipitor therapy significantly reduced hsCRP levels further than low-dose LipitorMagna Carta 8 Feb 2009
Lipitor appears to reduce risk of cardiovascular events compared with simvastatinmagna Carta 11 Dec 2008
Early treatment the best for patients with moderate to severe rheumatoid arthritisInZalo Communications 2 Sep 2008